title: Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
abstract: OBJECTIVE
  To determine whether changes in whole-lung pulmonary function test (PFT) values are related to the sum of predicted radiation therapy (RT)-induced changes in regional lung perfusion.
  
  
  METHODS
  Between 1991 and 1998, 96 patients (61% with lung cancer) who were receiving incidental partial lung irradiation were studied prospectively. The patients were assessed with pre- and post-RT PFTs (forced expiratory volume in one second [FEV1] and diffusion capacity for carbon monoxide [DLCO]) for at least a 6-month follow-up period, and patients were excluded if it was determined that intrathoracic recurrence had an impact on lung function. The maximal declines in PFT values were noted. A dose-response model based on RT-induced reduction in regional perfusion (function) was used to predict regional dysfunction. The predicted decline in pulmonary function was calculated as the weighted sum of the predicted regional injuries: equation [see text] where Vd is the volume of lung irradiated to dose d, and Rd is the reduction in regional perfusion anticipated at dose d.
  
  
  RESULTS
  The relationship between the predicted and measured reduction in PFT values was significant for uncorrected DLCO (P = .005) and borderline significant for DLCO (P = .06) and FEV1 (P = .08). However, the correlation coefficients were small (range,.18 to.30). In patients with lung cancer, the correlation coefficients improved as the number of follow-up evaluations increased (range,.43 to.60), especially when patients with hypoperfusion in the lung adjacent to a central mediastinal/hilar thoracic mass were excluded (range,.59 to.91).
  
  
  CONCLUSIONS
  The sum of predicted RT-induced changes in regional perfusion is related to RT-induced changes in pulmonary function. In many patients, however, the percentage of variation explained is small, which renders accurate predictions difficult.
authors.affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: M
authors.initials: M
authors.lastname: Fan
authors.forename: L B
authors.initials: LB
authors.lastname: Marks
authors.forename: D
authors.initials: D
authors.lastname: Hollis
authors.forename: G G
authors.initials: GG
authors.lastname: Bentel
authors.forename: M S
authors.initials: MS
authors.lastname: Anscher
authors.forename: G
authors.initials: G
authors.lastname: Sibley
authors.forename: R E
authors.initials: RE
authors.lastname: Coleman
authors.forename: R J
authors.initials: RJ
authors.lastname: Jaszczak
authors.forename: M T
authors.initials: MT
authors.lastname: Munley
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D008168:Lung / Q000528:radiation effects*; D008175:Lung Neoplasms / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D011446:Prospective Studies; D011878:Radiotherapy / Q000009:adverse effects; D012129:Respiratory Function Tests; D013899:Thoracic Neoplasms / Q000532:radiotherapy*